New York researchers at Mount Sinai are easing the relentless itch of eczema with a new drug. Dubbed a “breakthrough” therapy by the FDA, it treats eczema’s source rather than just its symptoms.
New York researchers at Mount Sinai are easing the relentless itch of eczema with a new drug. Dubbed a “breakthrough” therapy by the FDA, it treats eczema’s source rather than just its symptoms.